Loss of L-FABP and HNF-1α inactivation is a consistent feature of fibrolamellar carcinoma while HNF-1α mutation is an important occurrence in fibrolamellar carcinoma pathogenesis [13]. Here, FABP1 is linked to fibrolamellar hepatocellular carcinoma.